Home/Filings/4/A/0000921895-23-001593
4/A//SEC Filing

Activist Investing LLC 4/A

Accession 0000921895-23-001593

CIK 0000910267other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:14 PM ET

Size

9.9 KB

Accession

0000921895-23-001593

Insider Transaction Report

Form 4/AAmended
Period: 2023-06-21
Transactions
  • Sale

    Common Stock, par value $0.001

    2023-06-21$1.23/sh3,388,902$4,168,3490 total
  • Sale

    Common Stock, par value $0.001

    2023-06-21$1.23/sh359,066$441,6510 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock, par value $0.001

    2023-06-21$1.23/sh359,066$441,6510 total(indirect: By LLC)
  • Sale

    Common Stock, par value $0.001

    2023-06-21$1.23/sh3,388,902$4,168,3490 total
Footnotes (5)
  • [F1]These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
  • [F2]Prior to the filing of the Reporting Persons's Form 4 on June 23, 2023, the Reporting Person contacted the Issuer and advised the Issuer of his obligation to disgorge the "short-swing profit" realized by the Reporting Person, and that he was making preparation for payment of such disgorgement. Due to a ministerial error, such informaton was inadvertently excluded from the Form 4 filed by the Reporting Person on June 23, 2023.
  • [F3]This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
  • [F4]Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
  • [F5]Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother
IncorporatedNY

Related Parties

1
  • filerCIK 0001817604

Filing Metadata

Form type
4/A
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:14 PM ET
Size
9.9 KB